Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +1.15K | +1.02% | 114K | Apr 15, 2024 | Direct | F1 | ||
transaction | GBIO | Common Stock | Tax liability | -$1.25K | -337 | -0.3% | $3.70 | 114K | Apr 15, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -1.15K | -8.34% | $0.00 | 12.6K | Apr 15, 2024 | Common Stock | 1.15K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | On January 20, 2023, the reporting person was granted 18,345 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |